Prot# SP-1011-003: Fluticasone propionate Oral Dispersible Tablet Formulation in Eosinophilic Esophagitis: A Two-Part, Randomized, Double-blind, Placebo-Controlled Study of APT-1011 in Adult Subjects with Eosinophilic Esophagitis

Project: Research project

Project Details

StatusActive
Effective start/end date5/27/205/27/23

Funding

  • Syneos Health, Inc. (Prot# SP-1011-003)
  • Adare Pharmaceuticals, Inc. (Prot# SP-1011-003)